Febrile neutropenia in children with acute lymphoblastic leukemia (ALL);Neutropenia febril en menores con leucemia linfoblástica aguda

Revista Chilena de Pediatria

Volumn 75, Issue 2, 2004, Pages 146-152

  Hormaechea S, Amara ^a   Martínez D, Pilar ^a,b   Zolezzi R, Paola ^a   Folatre B, Isabel ^a,b   Cruz P, María Carolina ^b   Leal A, Nora ^b   Badilla M, Viviana ^b   Saldivia U, Paola ^b  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b Servicio de Salud Valdivia Hospital Clinico Regional Valdivia   (Chile)

Author keywords

Acute febrile neutropenia; Acute lymphoblastic leukemia; Bone marrow; Cancer

Indexed keywords

AMIKACIN; ANTINEOPLASTIC AGENT; CEFTRIAXONE; CLOXACILLIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CANDIDA; CHILD; CONTROLLED STUDY; FEBRILE NEUTROPENIA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRAM POSITIVE COCCI; HUMAN; MAJOR CLINICAL STUDY; TREATMENT OUTCOME;

EID: 2642529440     PISSN: 03704106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nachman J, Honig G: Fever and neutropenia in children with neoplastic disease. An analysis of 158 episodes. Cancer 1980; 45: 407-12.
2. Oppenhenhein B, Anderson H: Management of febrile neutropenia in low risk cancer patients. Thorax 2000; 55: 563-9.
3. Lanzkowsky P: Disorders of white blood cells. In Lanzkowsky Philip. A Manual of Pediatric Hematology and Oncology. New York, Churchill Livingstone Inc 1995; 159-83.
4. Giamarellou H, Antoniadou A: Infectious complications of febrile leukopenia. Infect Dis Clin North Am 2001; 15: 457-82.
5. Edwards J: International conference for the development of a consensus on the managment and prevention of severe candidal infections. Clin Infec Dis 1997; 25: 43-59.
6. Arola M: Respiratory virus infections during anticancer treatment in children. Pediatr Infec Dis J 1995; 14: 690-4.
7. Hughes W, Armstrong D, Bodey G, et al: 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infec Dis 2002; 34: 730-51.
8. Maertens J, Boogaerts M: Anti-infective strategies in neutropenic patients. Acta Clinica Belgica 1998; 53: 168-77.
9. Freifeld A, Marchigiani D, Walsh T, et al: A double blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341: 305-11.
10. Campbell M: Protocolo de Estudio y Tratamiento de Leucemia Linfoblástica Infantil. PINDA 96. Ministerio de Salud. Chile.
11. Comité de Farmacia, Hospital Clínico Regional Valdivia: Normas de uso de medicamentos, 1996.
12. Payá E, Álvarez A, Avilés C, et al: Agentes causantes de infecciones del torrente sanguíneo circulatorio en niños con cáncer, en cinco hospitales de Santiago (1994-1998). Rev Méd Chile 2001; 129: 1297-304.
13. Pérez A, Contreras A, Zolezzi P, et al: Infección por hongos en catéteres venosos centrales. Rev Chil Pediatr 2002; 73: 489-94.
14. Santolaya M, Alvarez A, Becker A, et al: Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 2001; 19: 3415-21.
15. Santolaya M: Neutropenia febril en el niño con cáncer. Conceptos actuales sobre criterios de riesgo y manejo selectivo. Rev Méd Chile 2001; 129: 1449-54.
16. Rubenstein E, Rolston K, Benjamin R, et al: Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993; 71: 3640-6.
17. Garcia-Carbonero R, Mayordomo J, Tornamira M, et al: Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomised trial. J National Cancer Institute. 2001; 93: 31-8.
18. Paganini H, Rodríguez-Brieshcke T, Zubizarreta P, et al: Oral Ciprofloxacin in the management of children with cancer with low risk febrile neutropenia. Cancer 2001; 91: 1563-7.
19. Aquino V, Herrera L, Sandler E, Buchanan G: Feasibility of oral Ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 2000; 88: 1710-4.
20. Rolston K, Rubenstein E, Freifeld A: Early empiric antibiotic therapy for febrile neutropenia patients at low risk. Cancer control 1996: 3: 366-74.
21. Rolston K: New trends in patients management: risk-based therapy for febrile patients with neutropenia: Clin Infec Dis 1999; 29: 515-21.
22. Tordecilla J, Campbell M, Joannon S, Rizzardini C, Soto V: Criterios de alta precoz en niños con cáncer y neutropenia febril. Rev Chil Pediatr 1998; 69: 247-51.
23. Ozer H, Armitage J, Bennett B, et al: 2000 Update of recomendations for the use of hematopoietic colony -stimulating factors: evidence- based, clinical practice guidelines. J Clin Oncol 2000; 18: 3558-85.